Cellphire Therapeutics, Inc.
Cellphire Therapeutics is a biotechnology company focused on developing platelet-based products to save lives. Our lead product, Thrombosomes, is a platelet-based freeze-dried hemostatic. Cellphire has the potential to create platelet-based products with applications across a wide range of therapeutic areas, including hemostasis, targeted drug delivery, and regenerative medicine.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Nationally (across the country)
About us
Our Goal
At Cellphire, we are redefining what is possible in transfusion medicine.
Cellphire's goal is to revolutionize hemostasis management through the development of the next generation platelet-based products that will efficiently stop bleeding. We believe that our products will ensure platelet availability to all patients regardless of location or environment.
Cellphire supports innovation in veterinary transfusion medicine.
Through our veterinary subsidiary, BodeVet®, we developed and launched the company’s first commercially available product, StablePlate RX® Canine, a canine freeze-dried platelet product with demonstrated efficacy in stopping bleeding in dogs. We are developing additional innovative transfusion medicine therapies for companion animals, including freeze-dried canine plasma. BodeVet® is also expanding its platelet work to support equine patients, as well as exotic animals such as elephants.
- Headquartered in Rockville, Maryland, our 32,000-square-foot facility includes 9,500 square feet of lab and clean-room manufacturing space.
- StablePlate RX® Canine, Thrombosomes, and research products are manufactured onsite.
- Our state-of-the-art cGMP facility consists of two separate manufacturing suites (one for veterinary and one for human products) that meet ISO 7 standards.
- The quality control laboratory is equipped with all analytical equipment necessary to test each lot for acceptability and support our discovery team’s research in new products.